Comparisons

Ozempic vs Victoza: Comparing Two Popular GLP-1 Medications

If you're exploring GLP-1 medications for type 2 diabetes or weight management, you've likely come across both Ozempic and Victoza. While these medications belong to the same drug class and work in similar ways, they have important differences that can affect your treatment experience. Let's break down what sets them apart so you can have an informed conversation with your healthcare provider.

What Are Ozempic and Victoza?

Both Ozempic and Victoza are injectable GLP-1 receptor agonists originally developed to help manage type 2 diabetes. They work by mimicking a natural hormone in your body that regulates blood sugar and appetite.

Ozempic contains semaglutide and was approved by the FDA in 2017. Victoza contains liraglutide and received FDA approval earlier, in 2010. While both medications help lower blood sugar levels, they've also gained attention for their weight loss benefits.

Key Differences Between Ozempic and Victoza

Dosing Schedule

One of the most significant differences is how often you need to take each medication.

Ozempic is injected once weekly, typically on the same day each week. This convenience factor makes it easier to remember and incorporate into your routine.

Victoza requires a daily injection, which means you'll need to administer it every single day, ideally at the same time. For some people, daily dosing offers more control, while others prefer the simplicity of a weekly injection.

Dosage Strengths

Ozempic starts at a lower dose of 0.25 mg weekly for the first month, then typically increases to 0.5 mg, with options to go up to 1 mg or even 2 mg depending on your response and goals.

Victoza starts at 0.6 mg daily and can be increased to 1.2 mg or a maximum of 1.8 mg daily. The daily dosing allows for more frequent adjustments if needed.

Weight Loss Results

Clinical studies show that Ozempic generally produces more significant weight loss compared to Victoza.

In clinical trials, people taking Ozempic lost an average of 12-14 pounds over 40 weeks at the 1 mg dose. With Victoza, average weight loss was around 5-7 pounds over a similar timeframe.

That said, individual results vary widely. Some people respond better to one medication than the other, and weight loss depends on many factors including diet, exercise, and individual metabolism.

Gender Considerations

Both medications work effectively in men and women, though research shows women may experience slightly more nausea initially with GLP-1 medications. This tends to improve over time as your body adjusts.

Women should note that both medications are not recommended during pregnancy or while breastfeeding. If you're planning to become pregnant, discuss this with your doctor well in advance, as you'll need to stop these medications beforehand.

Side Effects: What to Expect

Because Ozempic and Victoza work similarly in your body, they share many of the same potential side effects.

The most common side effects include:

Most side effects are mild to moderate and improve within the first few weeks as your body adjusts. Starting at a lower dose and gradually increasing helps minimize these effects.

Both medications carry similar warnings about potential risks, including pancreatitis and thyroid tumors in animal studies. Your doctor will review your personal and family medical history to ensure these medications are safe for you.

Cost Considerations

Without insurance, both medications can be expensive. Ozempic typically costs around $900-1,000 per month, while Victoza runs approximately $800-900 monthly.

Insurance coverage varies widely depending on your plan and whether you're using the medication for diabetes or weight loss. Many insurance plans cover these medications for type 2 diabetes but not for weight management alone.

This is where compounded alternatives like those offered through Ozari Health can provide a more affordable option for people seeking GLP-1 therapy for weight management.

Effectiveness for Blood Sugar Control

Both medications effectively lower A1C levels in people with type 2 diabetes.

Ozempic tends to produce slightly better A1C reductions, with studies showing average decreases of 1.5-1.8% from baseline. Victoza typically reduces A1C by about 1.0-1.5%.

For blood sugar management, both medications work best when combined with healthy eating habits and regular physical activity.

Which One Is Right for You?

Choosing between Ozempic and Victoza depends on several personal factors.

You might prefer Ozempic if you want once-weekly dosing, are looking for potentially greater weight loss, or respond well to semaglutide.

Victoza might be a better fit if you prefer daily dosing for more consistent medication levels, have used it successfully before, or if your doctor recommends it based on your specific health profile.

The best approach is to have an open conversation with your healthcare provider about your goals, lifestyle, and medical history. They can help determine which medication aligns best with your needs.

From the Ozari Care Team

Both Ozempic and Victoza can cause initial nausea that often improves within 2-3 weeks. To minimize discomfort, eat smaller, more frequent meals, avoid fatty or spicy foods, and stay well hydrated. If nausea persists beyond the first month or becomes severe, reach out to your provider about adjusting your dose or timing.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026